Andrew Schiff
DirectoratAclaris Therapeutics· In proxies 2023–2025
Andrew Schiff sits on 1 public board.
Experience
- Aclaris TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -74%
- Monte Rosa Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?